NCT03316729View on ClinicalTrials.gov

DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 31, 2018

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions

Pulmonary Embolism

Interventions

DRUG

DS-9231

DS-9231 in saline solution for intravenous infusion

DRUG

Placebo

Placebo is matching saline solution for intravenous infusion

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY